Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBC.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.26.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.26.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.26.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.26.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DS.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DS.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DS.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DS.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.27ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.27NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DV.6.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DV.6.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.6.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.11.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.11.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.11.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.11.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17890.7US
BA.2.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.4.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.4.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GM.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GM.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GM.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GM.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
BQ.1.1.20ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.20NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.26ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used